BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32357322)

  • 1. Vasopressor treatment and mortality following nontraumatic subarachnoid hemorrhage: a nationwide electronic health record analysis.
    Williams G; Maroufy V; Rasmy L; Brown D; Yu D; Zhu H; Talebi Y; Wang X; Thomas E; Zhu G; Yaseen A; Miao H; Leon Novelo L; Zhi D; DeSantis SM; Zhu H; Yamal JM; Aguilar D; Wu H
    Neurosurg Focus; 2020 May; 48(5):E4. PubMed ID: 32357322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Initial Vasopressors Used for Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.
    Roy B; McCullough LD; Dhar R; Grady J; Wang YB; Brown RJ
    Cerebrovasc Dis; 2017; 43(5-6):266-271. PubMed ID: 28319954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning prediction of the adverse outcome for nontraumatic subarachnoid hemorrhage patients.
    Yu D; Williams GW; Aguilar D; Yamal JM; Maroufy V; Wang X; Zhang C; Huang Y; Gu Y; Talebi Y; Wu H
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2178-2185. PubMed ID: 32990362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and effect of vasopressors after pediatric traumatic brain injury.
    Di Gennaro JL; Mack CD; Malakouti A; Zimmerman JJ; Armstead W; Vavilala MS
    Dev Neurosci; 2010; 32(5-6):420-30. PubMed ID: 21124016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Vasopressor Choice with Clinical and Functional Outcomes Following Moderate to Severe Traumatic Brain Injury: A TRACK-TBI Study.
    Toro C; Temkin N; Barber J; Manley G; Jain S; Ohnuma T; Komisarow J; Foreman B; Korley FK; Vavilala MS; Laskowitz DT; Mathew JP; Hernandez A; Sampson J; James ML; Goldstein BA; Markowitz AJ; Krishnamoorthy V;
    Neurocrit Care; 2022 Feb; 36(1):180-191. PubMed ID: 34341913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury.
    Toro C; Ohnuma T; Komisarow J; Vavilala MS; Laskowitz DT; James ML; Mathew JP; Hernandez AF; Goldstein BA; Sampson JH; Krishnamoorthy V
    Anesth Analg; 2022 Dec; 135(6):1245-1252. PubMed ID: 35203085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms.
    Reynolds MR; Buckley RT; Indrakanti SS; Turkmani AH; Oh G; Crobeddu E; Fargen KM; El Ahmadieh TY; Naidech AM; Amin-Hanjani S; Lanzino G; Hoh BL; Bendok BR; Zipfel GJ
    J Neurosurg; 2015 Oct; 123(4):862-71. PubMed ID: 26207606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressor use and effect on blood pressure after severe adult traumatic brain injury.
    Sookplung P; Siriussawakul A; Malakouti A; Sharma D; Wang J; Souter MJ; Chesnut RM; Vavilala MS
    Neurocrit Care; 2011 Aug; 15(1):46-54. PubMed ID: 20878264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior Reversible Encephalopathy Syndrome as a Complication of Induced Hypertension in Subarachnoid Hemorrhage: A Case-Control Study.
    Allen ML; Kulik T; Keyrouz SG; Dhar R
    Neurosurgery; 2019 Aug; 85(2):223-230. PubMed ID: 29889274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced Hypertension in Preventing Cerebral Infarction in Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.
    Haegens NM; Gathier CS; Horn J; Coert BA; Verbaan D; van den Bergh WM
    Stroke; 2018 Nov; 49(11):2630-2636. PubMed ID: 30355184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis.
    Dasenbrock HH; Yan SC; Gross BA; Guttieres D; Gormley WB; Frerichs KU; Ali Aziz-Sultan M; Du R
    J Neurosurg; 2017 Feb; 126(2):537-547. PubMed ID: 27058205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic Abnormalities Predict Adverse Clinical Outcomes in Patients with Subarachnoid Hemorrhage.
    Zhang L; Qi S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2653-2659. PubMed ID: 27476337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage.
    Miller JA; Dacey RG; Diringer MN
    Stroke; 1995 Dec; 26(12):2260-6. PubMed ID: 7491647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of nimodipine and vasopressors on outcome in patients with delayed cerebral ischemia after spontaneous subarachnoid hemorrhage.
    Paľa A; Schick J; Klein M; Mayer B; Schmitz B; Wirtz CR; König R; Kapapa T
    J Neurosurg; 2019 Mar; 132(4):1096-1104. PubMed ID: 30849754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003.
    Shea AM; Reed SD; Curtis LH; Alexander MJ; Villani JJ; Schulman KA
    Neurosurgery; 2007 Dec; 61(6):1131-7; discussion 1137-8. PubMed ID: 18162891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early low cerebral blood flow and high cerebral lactate: prediction of delayed cerebral ischemia in subarachnoid hemorrhage.
    Rostami E; Engquist H; Howells T; Johnson U; Ronne-Engström E; Nilsson P; Hillered L; Lewén A; Enblad P
    J Neurosurg; 2018 Jun; 128(6):1762-1770. PubMed ID: 28574309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Onset-to-Treatment Time With Discharge Destination, Mortality, and Complications Among Patients With Aneurysmal Subarachnoid Hemorrhage.
    Buscot MJ; Chandra RV; Maingard J; Nichols L; Blizzard L; Stirling C; Smith K; Lai L; Asadi H; Froelich J; Reeves MJ; Thani N; Thrift A; Gall S
    JAMA Netw Open; 2022 Jan; 5(1):e2144039. PubMed ID: 35061040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after Hunt and Hess Grade V subarachnoid hemorrhage: a comparison of pre-coiling era (1980-1995) versus post-ISAT era (2005-2014).
    Konczalla J; Seifert V; Beck J; Güresir E; Vatter H; Raabe A; Marquardt G
    J Neurosurg; 2018 Jan; 128(1):100-110. PubMed ID: 28298025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage.
    Schmidt JM; Wartenberg KE; Fernandez A; Claassen J; Rincon F; Ostapkovich ND; Badjatia N; Parra A; Connolly ES; Mayer SA
    J Neurosurg; 2008 Dec; 109(6):1052-9. PubMed ID: 19035719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.